Assessment of the Effects of Tegaserod in the Management of Gastroesophageal Reflux Disease (GERD) in Patients With Incomplete Response to Proton Pump Inhibitors (PPIs).
Clinical trial NCT00171418 · COMPLETED
Trial details
- NCT number
- NCT00171418
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.